The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Cochlear shares rise after UBS upgrades rating and price target
Cochlear shares rebounded by 2.9% to $270.21 following an upgrade from UBS, which changed its rating from 'sell' to 'neutral' and raised the price target from $270 to $285. This recovery comes after a significant 13.4% drop in the previous session due to lowered full-year profit expectations linked to reduced services revenue.
hearing aids market projected to reach 23.37 billion by 2032
The global Hearing Aids Market, valued at USD 13.16 billion in 2023, is projected to reach USD 23.37 billion by 2032, growing at a CAGR of 8.55%. This growth is driven by an aging population, technological advancements, and increasing awareness of hearing loss. Key players include Sonova, Demant, and GN Store Nord, among others.
ASX 200 Declines Amid Rate Cut Speculation Following Strong Jobs Report
The ASX 200 fell 19 points (-0.23%) to 8333, marking its lowest level in three weeks as markets reassessed the likelihood of an RBA interest rate cut in February following a strong November jobs report, which showed unemployment at 3.9%. The property and consumer discretionary sectors experienced notable declines, while the energy sector rebounded after crude oil prices rose above $70. Technical analysis indicates the index may close below a critical support level, potentially leading to further declines.
hearing aids market projected to grow significantly by 2031
The global Hearing Aids market is projected to grow from USD 8.10 billion in 2024 to USD 12.52 billion by 2031, with a CAGR of 6.4%. The report provides an extensive analysis of market dynamics, competitive landscape, and consumption trends, highlighting opportunities for growth amid evolving consumer preferences and technological advancements. Key players include Sonova, Starkey Laboratories, and GN Hearing, among others.
ASX 200 reaches new high fueled by US economic data and Fed comments
The ASX 200 reached a new milestone, surpassing 8500 points for the first time, driven by positive US economic data and dovish comments from Federal Reserve Chair Waller. Key sectors saw gains, with healthcare stocks like Ramsay Health Care rising 3.15% and technology stocks boosted by a record high in the Nasdaq 100. The market's upward momentum is supported by strong retail sales and improved manufacturing data from China.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.